source
- Generic drugmakers gain key victory in ‘skinny label’ patent caseThe Supreme Court ruled that a knockoff version of Amarin’s Vascepa didn’t infringe on patents — a decision with far-reaching implications for the availability of generics.BioPharma Dive · 1mo ago↗ source
- Innovent declares Phase 3 success for ADC that attracted huge Takeda dealInnovent Biologics' ADC candidate has passed a Phase 3 trial in advanced stomach cancer and is under priority review in China, but details of the success are still under wraps. The Phase 3 win will…Endpoints · 1mo ago↗ source
- Opinion: If Americans risk their lives fighting Ebola overseas, they deserve the right to come homeOutbreak response is difficult enough without asking responders to wonder whether they will have access to the best available care if they become ill.